NCT02921386View on ClinicalTrials.gov

The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 21, 2017

Study Completion Date

January 21, 2017

Conditions
Hypogonadism
Interventions
DRUG

Oral Testosterone Undecanoate

All study participants received Oral TU dose of 237 mg TU twice daily before breakfast and dinner for 14 days and throughout 5 crossover periods

Trial Locations (2)

90502

Harbor-UCLA Medical Center, Torrance

32809-3017

Orlando Clinical Research Center, Orlando

Sponsors

Collaborators (1)

Celerion
All Listed Sponsors
collaborator

Celerion

INDUSTRY

lead

Clarus Therapeutics, Inc.

INDUSTRY